Trellus Health plc (AIM: TRLS), a healthcare company delivering Trellus Elevatetm, a digital platform that integrates data analytics with personalized, scientifically proven resilience programs and ...

If you have an inflammatory bowel disease like Crohn’s or ulcerative colitis and have trouble focusing or remembering things, ...

Mindfulness-based interventions are of particular interest because of their potential to improve both the course of IBD and depression. Methods and analysis This study is a parallel design, ...

First subjects dosed in a Phase 2 trial of VTX3232 in participants with obesity and cardiometabolic risk factors, with topline data expected in ...

"Our study suggests that vedolizumab is a viable option for induction and long-term maintenance therapy in children with IBD, ...

Analysts have suggested that TL1A inhibitors could have blockbuster sales potential as second-line therapy for IBD refractory to first-line TNF biologics, with plenty of upside if they move into ...

upfront for rights to an anti-TL1A therapy being developed by Teva for inflammatory bowel disease, joining a race to bring the first drug in the class to market. Sanofi has acquired rights to co ...

Accepted by the Scottish Medicines Consortium for Adults with Moderately to Severely Active Ulcerative ColitisPRESS RELEASE – For UK consumer health, medical and trade media onlyRisankizumab will be ...

U.S. News released its list of best diets for 2025: the low-FODMAP diet landed on top for irritable bowel syndrome and the ...